Skip to main content
Clinical Trials/JPRN-UMIN000012209
JPRN-UMIN000012209
Recruiting
Phase 2

Assessment of medical treatment of diabetes on comorbid diastolic let-ventricular dysfunction observed by cardiac MRI in diabetic patients - DMDHF-CMR

Cardiology, Nagoya University0 sites50 target enrollmentNovember 4, 2013

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Heart failure with diastolic dysfunction and comorbid diabetes.
Sponsor
Cardiology, Nagoya University
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 4, 2013
End Date
September 30, 2016
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Cardiology, Nagoya University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • MACE within 3 months LVEF\<50% Comorbid atrial fibrillation MR at more than moderate grade Patients taking DPP4i or GLP\-1 analog ESRD or HD patient T1DM Malignancy within 5 years Uncontrolled arrhythmia Encontralled hypertension Expecting hospitalization within 6 months Insulin treatment Indication of cardiac surgery liver injury Autoimmune disease Pulmonary fibrosis Unstable AP or coronary spastic angina ASO (\>Fontaine grade II) Contraindication for MRI Drug allergy to sitagliptin and any antidiabetic drug.

Outcomes

Primary Outcomes

Not specified

Similar Trials